Crossmark

The first facile optical density-dependent approach for the analysis of doxorubicin, an oncogenic agent accompanied with the co-prescribed drug; paclitaxel

Crossref DOI link: https://doi.org/10.1186/s13065-023-00976-5

Published Online: 2023-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamad, Ahmed Abdulhafez https://orcid.org/0000-0002-7088-0723
Funding

Funding for this research was provided by:

Al-Azhar University
License Information

Text and Data Mining valid from 2023-06-16

Version of Record valid from 2023-06-16
More Information

Article History

Received: 23 October 2022

Accepted: 30 May 2023

First Online: 16 June 2023

Declarations

:

: The authors declare no competing interests.

: There is no conflict of interest to declare.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below